000136657 001__ 136657
000136657 005__ 20240229105052.0
000136657 0247_ $$2doi$$a10.1186/s13014-018-1060-8
000136657 0247_ $$2pmid$$apmid:29941049
000136657 0247_ $$2pmc$$apmc:PMC6020245
000136657 037__ $$aDKFZ-2018-01126
000136657 041__ $$aeng
000136657 082__ $$a610
000136657 1001_ $$00000-0003-2733-4134$$aBatista, Vania$$b0
000136657 245__ $$aSignificance of intra-fractional motion for pancreatic patients treated with charged particles.
000136657 260__ $$aLondon$$bBioMed Central$$c2018
000136657 3367_ $$2DRIVER$$aarticle
000136657 3367_ $$2DataCite$$aOutput Types/Journal article
000136657 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1536314172_14252
000136657 3367_ $$2BibTeX$$aARTICLE
000136657 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000136657 3367_ $$00$$2EndNote$$aJournal Article
000136657 520__ $$aUncertainties associated with the delivery of treatment to moving organs might compromise the accuracy of treatment. This study explores the impact of intra-fractional anatomical changes in pancreatic patients treated with charged particles delivered using a scanning beam. The aim of this paper is to define the potential source of uncertainties, quantify their effect, and to define clinically feasible strategies to reduce them.The study included 14 patients treated at our facility with charged particles (protons or 12C) using intensity modulated particle therapy (IMPT). Treatment plans were optimized using the Treatment Planning System (TPS) Syngo® RT Planning. The pre-treatment dose distribution under motion (4D) was simulated using the TPS TRiP4D and the dose delivered for some of the treatment fractions was reconstructed. The volume receiving at least 95% of the prescribed dose (V95CTV) and the target dose homogeneity were evaluated. The results from the 4D dose calculations were compared with dose distributions in the static case and its variation correlated with the internal motion amplitude and plan modulation, through the Pearson correlation coefficient, as well the significant p-value. The concept of the modulation index (MI) was introduced to assess the degree of modulation of IMPT plans, through the quantification of intensity gradients between neighboring pencil beams.The induced breathing motion together with dynamic beam delivery results in an interplay effect, which affects the homogeneity and target coverage of the dose distribution. This effect is stronger (∆V95CTV > 10%) for patients with tumor motion amplitude above 5 mm and a highly modulated dose distribution between and within fields. The MI combined with the internal motion amplitude is shown to correlate with the target dose degradation and a lack of plan robustness against range and positioning uncertainties.Under internal motion the use of inhomogeneous plans results in a decrease in the dose homogeneity and target coverage of dose distributions in comparison to the static case. Plan robustness can be improved by using multiple beams and avoiding beam entrance directions susceptible to density changes. 4D dose calculations support the selection of the most suitable plan for the specific patient's anatomy.
000136657 536__ $$0G:(DE-HGF)POF3-315$$a315 - Imaging and radiooncology (POF3-315)$$cPOF3-315$$fPOF III$$x0
000136657 588__ $$aDataset connected to CrossRef, PubMed,
000136657 7001_ $$aRichter, Daniel$$b1
000136657 7001_ $$aChaudhri, Naved$$b2
000136657 7001_ $$aNaumann, Patrick$$b3
000136657 7001_ $$aHerfarth, Klaus$$b4
000136657 7001_ $$0P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44$$aJäkel, Oliver$$b5$$eLast author$$udkfz
000136657 773__ $$0PERI:(DE-600)2224965-5$$a10.1186/s13014-018-1060-8$$gVol. 13, no. 1, p. 120$$n1$$p120$$tRadiation oncology$$v13$$x1748-717X$$y2018
000136657 909CO $$ooai:inrepo02.dkfz.de:136657$$pVDB
000136657 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)440a3f62ea9ea5c63375308976fc4c44$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000136657 9131_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000136657 9141_ $$y2018
000136657 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000136657 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000136657 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000136657 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000136657 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000136657 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000136657 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000136657 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000136657 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000136657 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000136657 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000136657 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000136657 9201_ $$0I:(DE-He78)E040-20160331$$kE040$$lMedizinische Physik in der Strahlentherapie$$x0
000136657 980__ $$ajournal
000136657 980__ $$aVDB
000136657 980__ $$aI:(DE-He78)E040-20160331
000136657 980__ $$aUNRESTRICTED